Skip to content
Markets News
Earnings1 min read

Novartis Raises 2026 Core Profit Outlook After Sales Growth

Makkler Newsroom
October 27, 2026 · Based on reporting by GlobeNewswire, finanzen.net

Third-quarter sales rose 4%, while Novartis lifted its full-year outlook for core operating income growth to flat to low single digits.

Key takeaways

  • Third-quarter net sales increased 4% to $14.5 billion.
  • Core operating income rose 10% at constant currencies.
  • Novartis raised its 2026 core operating income outlook.

Novartis raised its 2026 outlook for core operating income after third-quarter net sales climbed 4% to $14.5 billion. Core operating income increased 10% at constant currencies to $6.0 billion.

The company now expects full-year core operating income to be flat to up by a low single-digit percentage, versus its previous forecast of a low single-digit decline. Its outlook for net sales growth remains in the low single digits.

The core operating margin reached 41.6%, up 2 percentage points at constant currencies. Core earnings per share rose 8% at constant currencies to $2.46.

Reported operating income fell 61% at constant currencies, mainly because of a $1.9 billion partial impairment tied to the Del-Desiran research project. Net income dropped 71% on the same basis to $1.2 billion.

Novartis shares traded at CHF 129.24, up 1.38% from the previous close, as of 08:23 UTC on Tuesday.

Topics
NOVNNovartis

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.